IMIR Market Research, a leading UK market research firm, is pleased to announce its new report on Neurodiagnostics Market, forecast for 2023

seen from Germany

seen from Czechia

seen from Switzerland
seen from Australia

seen from Malaysia
seen from Türkiye
seen from Germany
seen from United States
seen from Netherlands
seen from Indonesia

seen from United States
seen from United States

seen from Czechia
seen from Hong Kong SAR China
seen from China
seen from United States
seen from United Kingdom
seen from India
seen from Poland
seen from United States
IMIR Market Research, a leading UK market research firm, is pleased to announce its new report on Neurodiagnostics Market, forecast for 2023
Neurodiagnostics Market Expected to Exceed USD 14.03 Billion by 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurodiagnostics Market Size, Share & Trends Analysis Report By Product (Diagnostic and Imaging Systems, Clinical Testing Instruments, Reagents & Consumables), By Condition (Neuro Degenerative Diseases, Epilepsy, Stroke), By End-Use (surgery centers, neurology centers, ambulatory care centers, diagnostic laboratories & imaging centers, and research laboratories & academic institutes)- Market Outlook And Industry Analysis 2031"
The global neurodiagnostic market is estimated to reach over USD 14.03 billion by 2031, exhibiting a CAGR of 7.12% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1683
Diagnostic tests are critical instruments in the diagnosis of neurological illnesses. Neuroimaging technologies, in vitro diagnostics, and neuroinformatics are the three segments of the neurodiagnostic market. Imaging techniques used in neuroimaging include computed tomography, magnetic resonance imaging, electroencephalography, and magneto-encephalography, among others. Conventional diagnostic therapies do not allow for early and reliable diagnosis, resulting in a strong demand for technologically enhanced diagnostic platforms. The global elderly population is continually expanding as life expectancy rises.
Neurological illnesses associated with aging, such as stroke, Alzheimer's disease, Parkinson's disease, and dementia, are also growing in frequency and prevalence. Moreover, with the increasing prevalence of neurological diseases worldwide, governments and non-governmental organizations are investing heavily in the development of diagnostics and therapeutics for treatment, as well as increasing funding and awareness programs for various neurological disorders, which may augment market growth.
List of Prominent Players in the Neurodiagnostics Market:
Advanced Brain Monitoring
ANT Neuro (Netherlands)
Bio-Rad Laboratories Inc.
Canon, Inc.
DRG Instruments GmbH (Germany)
ELMIKO MEDICAL Sp. Z o.o. (Poland)
F. Hoffmann-La Roche Ltd
Fonar Corporation (US)
FUJIFILM Holdings Corporation
Fujirebio (Japan)
GE Healthcare
Hitachi, Ltd.,
Koninklijke Philips N.V.
Lifelines Neuro
Mitsar Co. LTD.
Motion Lab Systems, Inc. (US)
Natus Medical Incorporated
Neusoft Medical Systems Co., Ltd. (US)
Nihon Kohden Corporation
QIAGEN N.V.
Ridge Diagnostics (US)
Rigaku Corporation (Japan)
Siemens Healthcare GmbH
Tecan Trading AG (Switzerland)
Thermo Fisher Scientific, Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
Diagnostic imaging manufacturers are investing in technology developments that will aid in the proper diagnosis of neurological illnesses. For instance, Medtronic PLC's Stealth Station S8 Neurosurgery System allows precise imaging and surgical navigation of every segment of the spine. 3D cameras, electromagnetic sensors, tracking algorithms, data processing software, and other technologies are included. Such technologies boost the global neurodiagnostic market by simplifying the diagnostic process.
Challenges:
Deployment of imaging technology involves a significant investment, and the high cost of these technologies limits their utilization, particularly in healthcare facilities in developing and low-income nations. The cost of an ultrasound machine can range from USD 20,000 to USD 200,000, with certain units costing considerably more. On the other hand, a PET scanner costs around USD 2 million, while an MRI scanner costs around USD 1 million. These sums are seen as prohibitively expensive, impeding market adoption and expansion.
Regional Trends:
The North American neurodiagnostic market is expected to register a substantial market share in terms of revenue and is projected to develop at a high CAGR in the near future. Technological advancements in brain monitoring equipment, increased healthcare spending, easy access to advanced instruments, a large number of manufacturing enterprises, and well-established medical infrastructure all contribute to overall regional market growth in the United States. The rising prevalence of neurological illnesses is raising demand for neurodiagnostic gadgets, which will drive market expansion in the Asia Pacific over the forecast period.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1683
Recent Developments:
In Dec 2022, Natus Medical, Inc. has reached an agreement to acquire Micromed Holding SAS ("Micromed Group" or "Micromed"), a global provider of neurophysiology solutions. Together, Natus and Micromed will offer customers the finest neurodiagnostic and neuromonitoring solutions in the industry.
In Aug 2021, Rigaku Corporation purchased all issued shares of MILabs B.V. as part of their comprehensive attempt to join the life sciences market. Rigaku will expand its life sciences modality business globally through this acquisition by combining MILabs' multi-modality businesses for animals, including PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), Optical Imaging, and CT (Computed Tomography), with Rigaku's original X-ray imaging business for animals.
In March 2021, At the commencement of the 2021 European Conference of Radiology, Hitachi Medical Systems unveiled two new permanent open MRI systems outfitted with the SynergyDrive workflow solution. GE Healthcare will unveil three new technologies, SIGNA 7.0T, SIGNA UHP 3.0T, and MAGNUS, in August 2020 to help neuro researchers better understand Alzheimer's disease and severe brain injury while also accelerating clinical translation.
Segmentation of Neurodiagnostics Market-
By Product-
Diagnostic and Imaging Systems
Electroencephalogram (EEG) Systems
Electromyography (EMG) Products
Magnetic Resonance Imaging (MRI) Systems
Ultrasound Imaging Systems
Computed Tomography (CT) Scanner
Magnetoencephalogram (MEG) System
Position emission tomography (PET) System
Angiography System
Others
Clinical Testing Instruments
PCR
Next-Generation Sequencing (NGS)
Sanger Sequencing
Others
Reagents & Consumables
Media and Serra
Solvents
Enzymes, Protein & Peptides
Probes
Buffers
Antibodies
Others
By Condition-
Neuro Degenerative Diseases
Epilepsy
Stroke
Headache Disorders
Sleep Disorders
Others
By End-Use-
Hospitals and Surgery Centers
Neurology Centers
Ambulatory Care Centers
Diagnostic Laboratories & Imaging Centers
Research Laboratories & Academic Institutes
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of the Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1683
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Next Generation Ultrasound Systems Market Set to Surge, Projected to Reach USD 19.52 Billion by 2031
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global Next Generation Ultrasound Systems Market (By Application (Monitoring and Diagnostics, Therapeutics), Usage Type (Temperature Patch, Blood Glucose Patch, Heart Rate and ECG Patch, TENS and EMS Patch, Others), End User (Hospital and Ambulatory Surgical Center, Homecare) - Market Outlook and Industry Analysis 2030" According to company's newest research, the Global Next Generation Ultrasound Systems Market is estimated to reach over USD 19.52 billion by 2031, exhibiting a CAGR of 8.79% during the forecast period for 2023-2031.
The rapidly growing population necessitates innovative and technologically advanced medical devices. Innovative healthcare quickly transitions from a traditional clinically engaged system to a distributed, patient-focused form. Artificial intelligence (AI) is generating enormous development and innovation in the healthcare industry. It is also accelerating drug research and discovery and enabling better and speedier diagnoses. Artificial intelligence (AI) has been shown to detect complex scan patterns and provide quantitative evaluations of imaging data.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1763
Artificial intelligence (AI) enables the automation of time-consuming duties, quantification and selection of the optimal image segment from a 3-D dataset, visual mapping and annotation of screened anatomy, and voice recognition for hands-free operation. E.g. For hands-free operation, the most recent iteration of the Konica Minolta Sonimage HS1 employs AI-voice recognition. The revolutionary V Flow for vascular hemodynamic evaluation and intelligent plane acquisition from 3D datasets for foetal CNS diagnosis augment the clinical research capabilities of Mindray Resona 7.
As ultrasound technologies are cost-effective, securer, and offer immediate diagnosis & treatment of target diseases, their demand in disease management is anticipated to grow during the forecast period. Spreading awareness regarding the benefits of next-generation ultrasound devices is expected to propel product demand. Furthermore, the ageing population, fast adoption of advanced technologies, increasing government initiatives for R&D of new ultrasound systems, rising awareness programs, high prevalence of chronic diseases, rising number of clinical trials and health-conscious pregnant women will help to upscale this market. However, the high cost of ultrasound technologies and the complexity of handling devices are limiting the growth of this market.
The prominent market players
BK Medical ApS (Analogic Corporation)
Butterfly Network, Inc.
Canon, Inc.
Clarius Mobile Health
Esaote SpA
Fujifilm Holdings Corporation
General Electric Company
Healcerion Co., Ltd.
Hitachi, Ltd.
Hologic, Inc.
Koninklijke Philips N.V.
Samsung Electronics Co., Ltd.
Shenzhen Mindray Bio-Medical
Electronics Co., Ltd.
Shimadzu Corporation
Siemens Healthineers AG
Other Prominent Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Next Generation Ultrasound Systems Market Report Scope
Report Attribute
Specifications
Market size value in 2022
USD 9.28 Bn
Revenue forecast in 2031
USD 19.52 Bn
Growth rate CAGR
CAGR of 8.79 % from 2023 to 2031
Quantitative units
Representation of revenue in US$ Billion, and CAGR from 2023 to 2031
Historic Year
2019 to 2022
Forecast Year
2023-2031
Report coverage
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends
Segments covered
Products, Technology, Application, Portability, End-Users
Regional scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia
Market Insights:
Next-generation ultrasound system refers to a device that combines a number of imaging diagnoses related to a wide variety of clinical segments. The next-generation ultrasound systems have various advanced technologies with better quality, portability, cost and high performance. Next-generation ultrasound systems are beneficial in the treatment of chronic diseases. COVID-19 Pandemic is significantly increasing the need for ultrasound system devices, and hence, in future, there will be a high requirement for ultrasound devices, which will ultimately result in the next-generation ultrasound systems market growth.
Regional Trends:
Geographically, the North American region is the major revenue holder of this market due to the high demand for ultrasound systems, the augmented prevalence of chronic diseases, and growing government investments in the R&D of next-generation ultrasound systems to treat various chronic diseases. On the other hand, Europe will also dominate the market during the projection period due to the fast adoption of medical technologies and the rising prevalence of chronic diseases. The Asia-Pacific market is anticipated to grow faster owing to growing ultrasound systems manufacturing industries and the high prevalence of chronic diseases.
The Key developments
In Nov 2022, At the Radiological Society of North America (RSNA), Philips announced the worldwide debut of a next-generation compact portable ultrasound system. The Compact 5000 Series from Philips intends to deliver the diagnostic quality associated with premium cart-based ultrasound equipment to a broader range of patients. The Compact 5000 series, designed for mobility and adaptability without compromising image resolution or performance, enables more patients to get first time-right ultrasound tests.
In July 2022, Siemens Healthineers exhibits its updated Acuson family at the European Congress of Radiology (ECR) in Vienna. The redesigned ultrasound product line is intended to provide even greater clinical adaptability and to meet the challenges of a variety of clinical applications. Launching 12 new transducers across four ultrasound systems and expanding AI-powered tools1 enables a new level of versatility, resulting in greater efficiency and consistency for clinicians.
In Nov 2020, Konica Minolta Healthcare Americas, Inc. unveiled the SONIMAGE HS2, a next-generation, small ultrasound system with increased picture quality and novel features designed for point-of-care applications. The HS2 System, which is based on the company's breakthrough ultrasound technology, provides higher picture quality and easier operation to enable doctors to address a wide range of therapeutic applications in musculoskeletal, vascular, pain management, interventional, and orthobiologics.
In September 2019, Butterfly Launched the New Ultrasound Technology in the U.K. A device has the potential to alter the way ultrasound scans are performed. In a nutshell, Butterfly Network's technology turns a smartphone into an ultrasound machine.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2444
Market Segmentation:
Global Next Generation Ultrasound Systems Market, by Application, 2023-2031 (Value US$ Bn)
Monitoring and Diagnostics
Therapeutics
Global Next Generation Ultrasound Systems Market, by Products, 2023-2031 (Value US$ Bn)
Diagnostic Ultrasound Systems
Therapeutic Ultrasound Systems
Global Next Generation Ultrasound Systems Market, by Technology, 2023-2031 (Value US$ Bn)
4D/3D Ultrasound Systems
2D Ultrasound Systems
Others (Fusion Imaging Tissue Harmonic Imaging)
Global Next Generation Ultrasound Systems Market, by Portability, 2023-2031 (Value US$ Bn)
Cart/Trolley-Based Systems
Handheld Devices and Wearables
Portable Systems
Global Next Generation Ultrasound Systems Market, by End-Users, 2023-2031 (Value US$ Bn)
Hospitals
Diagnostic Centers
Ambulatory Surgical Centers (ASCs)
Other End-User
Global Next Generation Ultrasound Systems Market, by Region, 2023-2031 (Value US$ Bn)
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
North America Next Generation Ultrasound Systems Market, by Country, 2023-2031 (Value US$ Bn)
U.S.
Canada
Europe Next Generation Ultrasound Systems Market, by Country, 2023-2031 (Value US$ Bn)
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific Next Generation Ultrasound Systems Market, by Country, 2023-2031 (Value US$ Bn)
India
China
Japan
South Korea
Australia & New Zealand
Latin America Next Generation Ultrasound Systems Market, by Country, 2023-2031 (Value US$ Bn)
Brazil
Mexico
Rest of Latin America
Middle East & Africa Next Generation Ultrasound Systems Market, by Country, 2023-2031 (Value US$ Bn)
GCC Countries
South Africa
Rest of Middle East & Africa
Why should buy this report:
To receive a comprehensive analysis of the prospects for the Next Generation Ultrasound Systems Market
To receive an industry overview and future trends of the Next Generation Ultrasound Systems Market
To analyze the Global Next Generation Ultrasound Systems Market drivers and challenges
To get information on the Global Next Generation Ultrasound Systems Market size (Value US$ Mn) forecast to 2031
Significant investments, mergers & acquisitions in the Global Next Generation Ultrasound Systems Market industry
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1763
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Neurodiagnostics Market Estimated to Witness High Growth Owing to Growing Geriatric Population
The neurodiagnostics market plays a crucial role in neurological disease diagnosis and treatment monitoring. Neurological disorders such as epilepsy, Alzheimer's disease, Multiple Sclerosis, Parkinson's disease, and other neurological conditions are becoming increasingly prevalent. Neurodiagnostics help detect neurological abnormalities through neurological imaging such as MRI, EEG, and diagnostic tests. The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics.
The Global Neurodiagnostics Market is estimated to be valued at US$ 8.66 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 To 2031.
Key Takeaways Key players operating in the neurodiagnostics are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.
The Neurodiagnostics Market Trends include increasing investments in R&D for biomarker-based disease diagnosis and neuroimaging. The global expansion of key players through mergers and acquisitions will further aid market growth.
The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics. Furthermore, increasing investments in R&D by key players for developing advanced diagnostic systems will boost the neurodiagnostics market over the forecast period.
Market drivers The growing geriatric population is the major driver propelling the Neurodiagnostics Market Size And Trends As per the United Nations, people aged over 60 years are projected to outnumber children under 10 years by 2050. Elderly people are more vulnerable to neurological disorders like Alzheimer's and Parkinson's disease. This will augment the demand for neurodiagnostics for early disease diagnosis and treatment monitoring. Increasing awareness about brain health and availability of reimbursement policies for neurodiagnostic tests will also boost market revenues significantly over the forecast period.
PEST Analysis Political: Regulations related to medical devices and neurological disorder treatments have an impact. Reimbursement policies by governments and insurance agencies also affect market growth. Economic: The growing insurance coverage levels and disposable incomes have boosted healthcare spending including on neurodiagnostics. Higher investments in clinical trials and R&D remain crucial. Social: Rising prevalence of neurological disorders like Alzheimers, Parkinsons, epilepsy, and stroke is a key driver. Growing awareness encourages early diagnosis through imaging techniques. Technological: Advancements in imaging modalities like MRI, CT, PET, EEG, and newer technologies like digital EEG and MEG expands diagnosis capabilities. Portable and wearable devices improve accessibility.
Geographical Regions with High Market Concentration North America accounts for the largest share in the neurodiagnostics market in terms of value, owing to the presence of major players, high healthcare expenditure, and rising neurological disorders. The United States holds a significant share in the regional market.
Fastest Growing Regional Market The Asia Pacific region is expected to witness the highest growth in the neurodiagnostics market during the forecast period. This is attributed to factors such as growing healthcare expenditure, increasing healthcare infrastructure development, and rising geriatric population in the region suffering from neurological conditions. Rapidly developing countries like China and India with huge patient pools offer high growth potential. Get More Insights On, Neurodiagnostics Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Neurodiagnostics Market Estimated to Witness High Growth Owing to Growing Geriatric Population
The neurodiagnostics market plays a crucial role in neurological disease diagnosis and treatment monitoring. Neurological disorders such as epilepsy, Alzheimer's disease, Multiple Sclerosis, Parkinson's disease, and other neurological conditions are becoming increasingly prevalent. Neurodiagnostics help detect neurological abnormalities through neurological imaging such as MRI, EEG, and diagnostic tests. The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics.
The Global Neurodiagnostics Market is estimated to be valued at US$ 8.66 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the neurodiagnostics are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.
The key opportunities in the Neurodiagnostics Market Demand include increasing investments in R&D for biomarker-based disease diagnosis and neuroimaging. The global expansion of key players through mergers and acquisitions will further aid market growth.
The growing geriatric population is more susceptible to neurodegenerative diseases, driving the need for neurodiagnostics. Furthermore, increasing investments in R&D by key players for developing advanced diagnostic systems will boost the neurodiagnostics market over the forecast period.
Market drivers
The growing geriatric population is the major driver propelling the Neurodiagnostics Market Size And Trends As per the United Nations, people aged over 60 years are projected to outnumber children under 10 years by 2050. Elderly people are more vulnerable to neurological disorders like Alzheimer's and Parkinson's disease. This will augment the demand for neurodiagnostics for early disease diagnosis and treatment monitoring. Increasing awareness about brain health and availability of reimbursement policies for neurodiagnostic tests will also boost market revenues significantly over the forecast period.
PEST Analysis
Political: Regulations related to medical devices and neurological disorder treatments have an impact. Reimbursement policies by governments and insurance agencies also affect market growth. Economic: The growing insurance coverage levels and disposable incomes have boosted healthcare spending including on neurodiagnostics. Higher investments in clinical trials and R&D remain crucial. Social: Rising prevalence of neurological disorders like Alzheimers, Parkinsons, epilepsy, and stroke is a key driver. Growing awareness encourages early diagnosis through imaging techniques. Technological: Advancements in imaging modalities like MRI, CT, PET, EEG, and newer technologies like digital EEG and MEG expands diagnosis capabilities. Portable and wearable devices improve accessibility.
Geographical Regions with High Market Concentration North America accounts for the largest share in the neurodiagnostics market in terms of value, owing to the presence of major players, high healthcare expenditure, and rising neurological disorders. The United States holds a significant share in the regional market.
Fastest Growing Regional Market
The Asia Pacific region is expected to witness the highest growth in the neurodiagnostics market during the forecast period. This is attributed to factors such as growing healthcare expenditure, increasing healthcare infrastructure development, and rising geriatric population in the region suffering from neurological conditions. Rapidly developing countries like China and India with huge patient pools offer high growth potential. Get More Insights On, Neurodiagnostics Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)
Neurodiagnostics Market Opportunities, Demand, Outlook and Forecasts 2022- 2027
Neurodiagnostics Market Opportunities, Demand, Outlook and Forecasts 2022- 2027
The Neurodiagnostics Market is predicted to witness a CAGR of 7% and market value is evaluated to reach up to USD 12,700 Million by the studied forecast period 2021-2028